126 related articles for article (PubMed ID: 6479861)
1. The blue glass and the predictive value of serum amino-terminal propeptide of type III procollagen as a marker of liver fibrosis.
Rojkind M
Hepatology; 1984; 4(5):977-8. PubMed ID: 6479861
[No Abstract] [Full Text] [Related]
2. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
[TBL] [Abstract][Full Text] [Related]
3. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
4. Type III procollagen amino terminal propeptide: what does it measure in children?
Wootton CI; Murphy R
Br J Dermatol; 2012 Dec; 167(6):1391-2. PubMed ID: 22578183
[No Abstract] [Full Text] [Related]
5. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
Zachariae H; Søgaard H; Heickendorff L
Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
[TBL] [Abstract][Full Text] [Related]
6. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
7. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis.
Gabrielli GB; Capra F; Casaril M; Squarzoni S; Tognella P; Dagradi R; De Maria E; Colombari R; Corrocher R; De Sandre G
Clin Chim Acta; 1997 Sep; 265(1):21-31. PubMed ID: 9352126
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions.
Gressner AM; Tittor W; Negwer A
Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173
[TBL] [Abstract][Full Text] [Related]
9. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
[TBL] [Abstract][Full Text] [Related]
10. Cryptogenic chronic active liver disease. Evaluation of serum aminoterminal peptide of type III procollagen as a marker of histological activity.
Diodati G; Bonetti P; Plebani M; Giacomini A; Rugge M; Realdi G; Burlina A
Ric Clin Lab; 1990; 20(4):253-9. PubMed ID: 2075377
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
[TBL] [Abstract][Full Text] [Related]
12. Serum aminoterminal propeptide of type III procollagen in the management of methotrexate-induced fibrogenesis.
Kürkçüoğlu N; Oz G
J Am Acad Dermatol; 1992 Jul; 27(1):139. PubMed ID: 1619068
[No Abstract] [Full Text] [Related]
13. [Procollagen Type III-N-terminal peptide as an indicator of hepatic fibrogenesis].
Sajewicz Z; Poniewierka E
Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):325-6. PubMed ID: 2235718
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of measuring the level of procollagen type III peptide in the evaluation of liver fibrosis in children].
Swiatkowska E; Socha J; Bogoniowska Z; Leśniewska A; Malenta G; Oralewska B
Pol Tyg Lek; 1988 Apr; 43(14):441-3. PubMed ID: 3412979
[No Abstract] [Full Text] [Related]
15. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
Bentsen KD; Henriksen JH; Bendtsen F; Hørslev-Petersen K; Lorenzen I
Hepatology; 1990 Jun; 11(6):957-63. PubMed ID: 2365293
[TBL] [Abstract][Full Text] [Related]
16. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?
Surrenti C; Casini A; Milani S; Ambu S; Ceccatelli P; D'Agata A
Dig Dis Sci; 1987 Jul; 32(7):705-9. PubMed ID: 3595382
[TBL] [Abstract][Full Text] [Related]
17. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity.
McCullough AJ; Stassen WN; Wiesner RH; Czaja AJ
Hepatology; 1987; 7(1):49-54. PubMed ID: 3492417
[TBL] [Abstract][Full Text] [Related]
18. [Assay of an amino propeptide of procollagen III in hepatic pathology].
Lefrère JJ; Arrago JP; Poirier O; Najean Y
Ann Med Interne (Paris); 1987; 138(8):667. PubMed ID: 3450217
[No Abstract] [Full Text] [Related]
19. A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis.
Fabris C; Falleti E; Federico E; Toniutto P; Pirisi M
Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():151-5. PubMed ID: 9133247
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.
Tanaka Y; Minato Y; Hasumura Y; Takeuchi J
Dig Dis Sci; 1986 Jul; 31(7):712-7. PubMed ID: 3720468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
